Search research articles
Contact Us
Filters
Showing results (91-100 of 242) with videos related to
Page
of 25
Sort By:
General Hospital Psychiatry
|
February 28, 2001
Clinical utility and validation of the Japanese version of Memorial Delirium Assessment Scale in a psychogeriatric inpatient setting
Y Matsuoka, Y Miyake, H Arakaki, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1994
Endothelin ETB receptors couple to two distinct signaling pathways in porcine kidney epithelial LLC-PK1 cells
S Ozaki, M Ihara, T Saeki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 20, 2009
Evaluation of the safety and tolerability of oral TAS-108 in postmenopausal patients with metastatic breast cancer
T Saeki, S Noguchi, K Aogi, et al.
Japanese Journal of Pharmacology
|
January 1, 1993
Inhibitory effects of a novel antiplatelet agent, E5510, on collagen-induced platelet-derived growth factor release and aggregation of human platelets in vitro
K Nomoto, T Saeki, M Kogushi, et al.
Nucleic Acids Symposium Series
|
January 1, 1997
Synthesis and properties of carbocyclic oligothymidylate lacking the 5'-methylene
M Koga, M Yamamoto, T Nishi, et al.
Japanese Journal of Pharmacology
|
January 1, 1991
A new anti-platelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human platelets
T Fujimori, K Harada, T Saeki, et al.
The Tohoku Journal of Experimental Medicine
|
April 1, 1986
Citrullinemia: quantitative deficiency of argininosuccinate synthetase in the liver
K Oyanagi, Y Itakura, A Tsuchiyama, et al.
Bioscience, Biotechnology, and Biochemistry
|
June 5, 2001
Soybean resistant proteins interrupt an enterohepatic circulation of bile acids and suppress liver tumorigenesis induced by azoxymethane and dietary deoxycholate in rats
R Kanamoto, N Azuma, T Miyamoto, et al.
Journal of Medicinal Chemistry
|
June 24, 1994
Cyclic GMP phosphodiesterase inhibitors. 2. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity
Y Takase, T Saeki, N Watanabe, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1995
A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery
T Saeki, H Adachi, Y Takase, et al.
Page
of 25
Search research articles
Search
Showing results (91-100 of 242) with videos related to
Sort By:
Page
of 25
General Hospital Psychiatry
|
February 28, 2001
Clinical utility and validation of the Japanese version of Memorial Delirium Assessment Scale in a psychogeriatric inpatient setting
Y Matsuoka, Y Miyake, H Arakaki, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1994
Endothelin ETB receptors couple to two distinct signaling pathways in porcine kidney epithelial LLC-PK1 cells
S Ozaki, M Ihara, T Saeki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 20, 2009
Evaluation of the safety and tolerability of oral TAS-108 in postmenopausal patients with metastatic breast cancer
T Saeki, S Noguchi, K Aogi, et al.
Japanese Journal of Pharmacology
|
January 1, 1993
Inhibitory effects of a novel antiplatelet agent, E5510, on collagen-induced platelet-derived growth factor release and aggregation of human platelets in vitro
K Nomoto, T Saeki, M Kogushi, et al.
Nucleic Acids Symposium Series
|
January 1, 1997
Synthesis and properties of carbocyclic oligothymidylate lacking the 5'-methylene
M Koga, M Yamamoto, T Nishi, et al.
Japanese Journal of Pharmacology
|
January 1, 1991
A new anti-platelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human platelets
T Fujimori, K Harada, T Saeki, et al.
The Tohoku Journal of Experimental Medicine
|
April 1, 1986
Citrullinemia: quantitative deficiency of argininosuccinate synthetase in the liver
K Oyanagi, Y Itakura, A Tsuchiyama, et al.
Bioscience, Biotechnology, and Biochemistry
|
June 5, 2001
Soybean resistant proteins interrupt an enterohepatic circulation of bile acids and suppress liver tumorigenesis induced by azoxymethane and dietary deoxycholate in rats
R Kanamoto, N Azuma, T Miyamoto, et al.
Journal of Medicinal Chemistry
|
June 24, 1994
Cyclic GMP phosphodiesterase inhibitors. 2. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity
Y Takase, T Saeki, N Watanabe, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1995
A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery
T Saeki, H Adachi, Y Takase, et al.
Page
of 25